ICUI

$125.36-1.27 (-1.00%)

Market ClosedAs of Mar 20, 8:00 PM UTC

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide.

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$125.36
Potential Downside
99.6%
Whystock Fair Value$0.53
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Instruments & Supplies

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. It offers infusion therapy products, such as needlefree products un...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$3.10B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
4178.67
Beta
Defensive asset. Lower volatility than the S&P 500.
0.81
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-1.74%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
1.15

Recent News

MarketBeat
Mar 20, 2026

ICU Medical Details 2026 EBITDA Outlook, Smiths Integration Progress at KeyBanc Healthcare Forum

ICU Medical (NASDAQ:ICUI) executives outlined the assumptions behind the company’s 2026 outlook and provided updates on operations, product momentum, and the multi-year Smiths integration during a Q&A session at the KeyBanc Healthcare Forum. CEO Vivek Jain and CFO Brian Bonnell reiterated that t

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 16, 2026

3 Profitable Stocks We Keep Off Our Radar

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 12, 2026

3 Russell 2000 Stocks We Steer Clear Of

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 9, 2026

2 Healthcare Stocks with Exciting Potential and 1 We Avoid

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, which has supported the industry’s returns lately - over the past six months, healthcare stocks have gained 5.7%, nearly mirrorring the S&P 500.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 6, 2026

Integra LifeSciences, GE HealthCare, Bausch + Lomb, ICU Medical, and Universal Health Services Shares Are Falling, What You Need To Know

A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the healthcare industry showing significant job losses.

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.